Company Description
Accuray Incorporated engages in the design, development, and sale of radiosurgery and radiation therapy systems for the treatment of tumors throughout the body in the United States, Canada, Latin America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China.
The company offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate.
It also provides the TomoTherapy platform, including the Radixact System, a tailored helical solution, which integrates radiation treatment planning, delivery, imaging, and data management; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems.
In addition, the company offers post-contract customer support, installation, training, and other professional services.
It primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally.
Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.
| Country | United States |
| Founded | 1990 |
| IPO Date | Feb 8, 2007 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 809 |
| CEO | Stephen LaNeve |
Contact Details
Address: 1240 Deming Way Madison, Wisconsin 53717-1954 United States | |
| Phone | 608 824 2800 |
| Website | accuray.com |
Stock Details
| Ticker Symbol | ARAY |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | July - June |
| Reporting Currency | USD |
| CIK Code | 0001138723 |
| CUSIP Number | 004397105 |
| ISIN Number | US0043971052 |
| Employer ID | 20-8370041 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Stephen R. LaNeve MBA | President, Chief Executive Officer and Director |
| Ali Pervaiz | Senior Vice President and Chief Financial Officer |
| Paul Miele | Senior Vice President and Chief Commercial Officer |
| Michael J. Murphy CPA | Corporate Controller and Principal Accounting Officer |
| David Shin | Senior Vice President, Chief Legal Officer and Corporate Secretary |
| Dr. Seth Blacksburg M.B.A., M.D. | Senior Vice President and Chief Medical and Marketing Officer |
| Jim Dennison | Senior Vice President and Chief Quality and Regulatory Affairs Officer |
| Xavier De Misouard | President and GM of EIMEA Region |
| John M. Dunn | Chief Product Development and Digital Officer |
| Todd M. Brown | Senior Vice President of Enterprise Performance Optimization |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 6, 2026 | 10-Q | Quarterly Report |
| Nov 4, 2026 | 8-K | Current Report |
| Nov 4, 2026 | 8-K | Current Report |
| Oct 30, 2026 | S-8 | Securities to be offered to employees in employee benefit plans |
| Oct 16, 2026 | ARS | Filing |
| Oct 16, 2026 | DEF 14A | Other definitive proxy statements |
| Oct 13, 2026 | 8-K | Current Report |
| Oct 6, 2026 | 8-K | Current Report |
| Sep 18, 2026 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Sep 11, 2026 | EFFECT | Notice of Effectiveness |